DSUVIA (sufentanil) Drug Insights and U.S. Market Analysis, 2023-2032
January 30, 2024 08:01 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "United States DSUVIA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This extensive report...
MAXIGESIC IV Drug Insight and U.S. Market Forecasts to 2032: In-depth Product Overview, Regulatory Milestones, Competitive Landscape Analysis, and SWOT Analysis
January 29, 2024 12:15 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "United States MAXIGESIC IV Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Dual Mode-of-Action...
ANJESO Drug Insight and Market Forecast in the United States, 2023-2032: Developmental Milestones, Intellectual Property Insights, Future Market Forecast, and SWOT Analysis with Sales Projections
January 29, 2024 12:14 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "United States ANJESO Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
United States OLINVYK Drug Insight and Market Forecasts, 2019-2032: A Novel G Protein-biased (selective) Mu-opioid Receptor (MOR) Ligand Approved to Manage Acute Pain
January 24, 2024 07:43 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "United States OLINVYK Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...